Results for tag: "Oncology Companion Diagnostics"

Oncology Companion Diagnostics (OCD) are a type of diagnostic test used to identify and monitor cancer patients. These tests are used to detect the presence of cancer, determine the type of cancer, and assess the patient's response to treatment. OCDs are used to identify genetic mutations that may be associated with the development of cancer, as well as to identify biomarkers that can be used to predict the risk of cancer recurrence. OCDs are also used to monitor the progression of cancer and to determine the effectiveness of treatment. OCD tests are typically performed in conjunction with other diagnostic tests, such as imaging and biopsy. They are used to provide a more comprehensive picture of the patient's cancer and to guide treatment decisions. Companies in the Oncology Companion Diagnostics market include Roche, Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more